Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. (Q40611458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Christopher G. Parsons

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Eisensamer B

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Rammes G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Shapa M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ferrari U

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hapfelmeier G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Bondy B

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Gilling K

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Zieglgänsberger W

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Rupprecht R

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Holsboer F

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

994-1007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647397%20AND%20SRC:MED&resulttype=core&format=json

Current trends in the development of new antidepressants

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

A Molecular and Cellular Theory of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Inhibition of the serotonin 5-HT3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

The 5-HT3B subunit is a major determinant of serotonin-receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Nervous system distribution of the serotonin 5-HT3 receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Treatment of established postoperative nausea and vomiting: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Neurosteroids and GABAA receptor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Cytosolic free [Ca2+] in mononuclear blood cells from demented patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Effects of antidepressants on the inward current mediated by 5‐HT3 receptors in rat nodose ganglion neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Ion permeation and conduction in a human recombinant 5-HT3 receptor subunit (h5-HT3A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

A synaptic model of memory: long-term potentiation in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

The location of the gate in the acetylcholine receptor channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Effect of imipramine on the membrane anisotropy and on the phospholipid methylation in the central nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Differential effects of tricyclic antidepressant drugs on membrane dynamics--a fluorescence spectroscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Nongenomic effects of steroids on the nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

Physiological genomics of antidepressant targets: keeping the periphery in mind.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

Inhibition of a 5-HT3 receptor-mediated current by the selective serotonin uptake inhibitor, fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

Ondansetron for hallucinosis in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021

Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001314

7 January 2021